An evaluation of the impact of MAPT, SNCA and APOE on the burden of Alzheimer's and Lewy body pathology. - Wikidata - awgldk - TriplyDB

An evaluation of the impact of MAPT, SNCA and APOE on the burden of Alzheimer's and Lewy body pathology.

An evaluation of the impact of MAPT, SNCA and APOE on the burden of Alzheimer's and Lewy body pathology.

http://www.wikidata.org/entity/Q36758618

about

The Genetic Basis of Cognitive Impairment and Dementia in Parkinson's Disease Association of Parkinson disease risk loci with mild parkinsonian signs in older persons.PART is part of Alzheimer disease.When DLB, PD, and PSP masquerade as MSA: an autopsy study of 134 patients Transcranial magnetic stimulation and transcranial direct current stimulation: treatments for cognitive and neuropsychiatric symptoms in the neurodegenerative dementias?Uptake and mitochondrial dysfunction of alpha-synuclein in human astrocytes, cortical neurons and fibroblasts.Association between MAPT haplotype and memory function in patients with Parkinson's disease and healthy aging individuals.The effects of two polymorphisms on p21cip1 function and their association with Alzheimer's disease in a population of European descent Regulation of human MAPT gene expression.Mitochondrial targeting sequence variants of the CHCHD2 gene are a risk for Lewy body disorders Sequence variants in eukaryotic translation initiation factor 4-gamma (eIF4G1) are associated with Lewy body dementia Cerebrospinal fluid Aβ levels correlate with structural brain changes in Parkinson's disease Cerebellar ataxia in progressive supranuclear palsy: An autopsy study of PSP-C.The effect of MAPT haplotype on neocortical Lewy body pathology in Parkinson disease.Disentangling the effects of age and APOE on neuropathology and late life cognitive decline Genetic and neuroanatomic associations in sporadic frontotemporal lobar degeneration.Relationship between genetic risk factors and markers for Alzheimer's disease pathology.Genetics and underlying pathology of dementia.Role of Apolipoproteins and α-Synuclein in Parkinson's Disease.Interactions Between α-Synuclein and Tau Protein: Implications to Neurodegenerative Disorders.The associations between the MAPT polymorphisms and Alzheimer's disease risk: a meta-analysis Genetic Architecture of MAPT Gene Region in Parkinson Disease Subtypes.Copy number variation analysis of the 17q21.31 region and its role in neurodegenerative diseases.Association analysis of the GRN rs5848 and MAPT rs242557 polymorphisms in Parkinson's disease and multiple system atrophy: a large-scale population-based study and meta-analysis.Association of a BACE1 Gene Polymorphism with Parkinson's Disease in a Norwegian Population.Parkinson's disease susceptibility variants and severity of Lewy body pathology.Distribution and characteristics of transactive response DNA binding protein 43 kDa pathology in progressive supranuclear palsy.Atrophy of the cholinergic basal forebrain in dementia with Lewy bodies and Alzheimer's disease dementia.Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies.

P2860

Q26744716-3A578485-4576-4C28-BC96-70DC9F454D2B Q33688838-7E2A2CD6-A7DF-4CFE-B64A-4602BCFDA566 Q34460027-9F6F6310-E444-48B5-B8D9-FD212F5F7926 Q34483397-A6A082D8-BA77-4DE2-8A6D-434BD28FC330 Q34631108-D303DBDF-BEF4-4418-86A5-64892AEB7745 Q35008102-66DC6D89-CC95-45C5-B047-4E71E84824A5 Q35158915-4CE4C10F-2B1A-4BAA-BDBB-D94F01B9F4F6 Q35549840-6DEB9574-9542-40F6-986D-DA6559220DA2 Q35844758-3AA612FF-8DD3-44C9-9BE5-953CED750880 Q36365785-C86E4C07-945F-4781-89DC-01FFAC7CC244 Q36631666-DC7C91A3-493E-4C31-9E7A-CBAD069D8EFF Q36718213-F0D5707F-6D2B-401C-83BC-9947621A3935 Q36885378-133E88E7-BE44-4C57-B98F-B2E2D757F6E6 Q37082285-928081A7-75FA-47F5-9672-EC0A03543AB9 Q37438618-A2FC66AE-F4CA-4423-9113-E513073F4454 Q37652962-5E145D32-098B-47C8-90C4-4D91E3FADAB9 Q38037159-11990B14-1CDF-4793-A15F-5D5FB20E9D3E Q38310765-1C6F6990-6681-4854-B121-7014CB310427 Q38659590-6B791956-3E56-45C3-B838-D854FC851D0D Q38954686-A27790B5-B08B-4879-A67E-A1E43E1559F0 Q39246359-1A3EE721-1764-43B1-AC3D-D8BE76EECD23 Q40012093-1AA7521E-63C6-4371-A6D4-64F37188B087 Q40321087-D43EC51B-9419-49C1-BFA5-01DC7844E20B Q40612239-23663F16-ED8C-46B9-9A6D-8BF94D1D641E Q42178133-88FD2019-4827-456A-936E-E24701ECE342 Q48109944-13DF9B42-1765-4397-AD11-967DC6B4F276 Q48122054-7D27039D-8D9A-4AD3-9207-9ED97EBB5F13 Q48639125-B1A6270D-02AE-4DAC-995B-73C197BBBD27 Q49987358-F2663821-B787-4EE3-B16C-D729B8E2ABB9

P2860

An evaluation of the impact of MAPT, SNCA and APOE on the burden of Alzheimer's and Lewy body pathology.

http://www.wikidata.org/entity/Q36758618

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

An evaluation of the impact of ...... mer's and Lewy body pathology.

@ast

An evaluation of the impact of ...... mer's and Lewy body pathology.

@en

type

label

An evaluation of the impact of ...... mer's and Lewy body pathology.

@ast

An evaluation of the impact of ...... mer's and Lewy body pathology.

@en

prefLabel

An evaluation of the impact of ...... mer's and Lewy body pathology.

@ast

An evaluation of the impact of ...... mer's and Lewy body pathology.

@en

P1433

Q36758618-F3FEEDE4-C00E-4B81-B031-896B7CF2286A

P1476

Q36758618-0A32C013-59B3-4BE9-8FEE-97BCDBDCE9BF

P2093

Q36758618-1C13BF1E-BA8E-493A-9E4E-7B831E0698D5

Q36758618-30270809-A823-4DE4-B9E0-913E801B11E3

Q36758618-612EFD92-D4FE-46AF-ACFF-B925D7EBA830

Q36758618-6D15F3F2-7A09-44EB-AE09-7488DE143C7A

Q36758618-A0AF647C-CC56-4315-BFB5-C7A54C8EE6E1

Q36758618-AC21968D-387D-4AD5-9389-926746AAE818

Q36758618-B597A50D-25E9-4C3B-BA6D-7D3BBB5139DC

Q36758618-CE40AA83-FE4A-4B31-85E2-50E53865E869

Q36758618-ECA4828D-0FF1-476E-AADF-EFB1A1BFA44D

P2860

Q36758618-01E17E2E-C9EC-43AF-BD45-48E157F065CA

Q36758618-02204388-4167-40C3-B1B8-795FC8480C06

Q36758618-0C3A92CF-767B-4EA8-BB79-5B8EBAB62826

Q36758618-0C4CC60F-9E98-4A7A-B431-678134C9F26E

Q36758618-13D7BCED-7626-41E2-961D-7545D12D6ECC

Q36758618-1FEEDEB8-3097-44BB-A818-F8B67490FFFA

Q36758618-27B20756-3E5E-4CF6-90DC-5DAB42CAD441

Q36758618-28F371CE-DD70-439D-A39A-09041D473794

Q36758618-2EAE42EA-F1DC-4417-A234-1906827AC2F9

Q36758618-300C452E-3478-4831-805F-DF1B2BCE1857

P304

Q36758618-F5A25F41-6A36-47B9-9F9C-0EA3C0A38592

P31

Q36758618-91EBF026-2B5A-4B20-AD9E-F0FED2CD3298

P356

Q36758618-D3D19648-3A56-4B61-938C-7ED0BB4EE803

P407

Q36758618-D89970C4-306B-4255-BD8E-99A7256636C6

P433

Q36758618-5962E8F1-2A67-47FA-9BC2-9995CEC55AAD

P478

Q36758618-9284F37C-031F-4F26-82E9-A2BE2B4B60B5

P50

Q36758618-2AF4AFBA-A323-456B-AE73-9FD65DC2C2FB

Q36758618-871792AA-524B-4AC5-8377-E67FF79074BC

Q36758618-A029BDE1-9E4B-4F29-AA84-D7237625B872

Q36758618-B3504787-EC64-4635-8F1F-31EEA02D8D8C

Q36758618-C2486AE4-ECBF-4846-9719-173FA08F4622

Q36758618-D15DA5C9-1C31-4D00-A3B9-82F8B6727B28

Q36758618-F9C08F0D-ED3E-4EDE-AE5C-67150D39D406

P577

Q36758618-0BA41A84-247D-4E12-9192-20B6773175B8

P5875

Q36758618-5BCAC39F-8C34-4EE7-9A15-64ACF67F54A7

P698

Q36758618-EFEBAE9B-E4D4-430E-87E5-99E3886F32F6

P921

Q36758618-6ECAAAE2-3DC9-4FDF-A253-65249CC3171F

P932

Q36758618-46A26162-050B-4C4E-8BF5-0D2208A9D691

P356

JNNP-2011-301413

P1433

Journal of Neurology, Neurosurgery and Psychiatry

P1476

An evaluation of the impact of ...... mer's and Lewy body pathology.

@en

P2093

Christian Wider

http://www.w3.org/2001/XMLSchema#string

Deborah C Mash

http://www.w3.org/2001/XMLSchema#string

Hirotake Uchikado

http://www.w3.org/2001/XMLSchema#string

Kenya Nishioka

http://www.w3.org/2001/XMLSchema#string

Michael G Heckman

http://www.w3.org/2001/XMLSchema#string

Neill R Graff-Radford

http://www.w3.org/2001/XMLSchema#string

Nilufer Erketin-Taner

http://www.w3.org/2001/XMLSchema#string

Ranjan Duara

http://www.w3.org/2001/XMLSchema#string

Spiridon Papapetropoulos

http://www.w3.org/2001/XMLSchema#string

P2860

Apolipoprotein E, Dementia, and Cortical Deposition of β-Amyloid Protein

Interface between tauopathies and synucleinopathies: A tale of two proteins

Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease

Neuropathological stageing of Alzheimer-related changes

GSK3B polymorphisms alter transcription and splicing in Parkinson's disease

Staging of brain pathology related to sporadic Parkinson's disease

Comparative biochemistry of tau in progressive supranuclear palsy, corticobasal degeneration, FTDP-17 and Pick's disease

Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease

Concurrence of alpha-synuclein and tau brain pathology in the Contursi kindred.

APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging.

P304

424-429

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/JNNP-2011-301413

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

83

http://www.w3.org/2001/XMLSchema#string

P50

Carles Vilariño-Güell

Rosa Rademakers

Dennis W. Dickson

Matthew J. Farrer

Zbigniew K Wszolek

Barbara Jasinska-Myga

P577

2012-01-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221792616

http://www.w3.org/2001/XMLSchema#string

P698

22291217

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

3623699

http://www.w3.org/2001/XMLSchema#string